It adds to other variables recently suggested to affect the interaction of GLP-1R agonists with depression, which include existing and treated diabetes or obesity, age, duration of treatment, whether comparisons are made to control groups receiving placebo or other antiobesity medications, and whether patients with preexisting psychiatric diagnosis are included. Here, GLP1R is linked to diabetes mellitus.